Medicine and Dentistry
Cystectomy
100%
Transitional Cell Carcinoma
82%
Bladder
73%
Prostate Cancer
59%
Gleason Score
54%
Prostatectomy
43%
Surgical Margin
43%
Cancer Staging
31%
Holmium
28%
Enucleation
28%
Prevalence
28%
Lymphocele
28%
Partial Nephrectomy
28%
Neoplasm
28%
Survival Rate
26%
Biochemical Recurrence
25%
Biopsy
25%
Cancer Specific Survival
25%
Urology
20%
Laparoscopic Surgery
19%
Prostate Specific Antigen
18%
Lymphovascular Invasion
17%
Proportional Hazards Model
16%
Laparoscopy
16%
Malignant Neoplasm
16%
Transrectal Ultrasonography
15%
Peroperative Complication
14%
Testes
14%
Anticoagulation
14%
Harmonic Imaging
14%
Radical Retropubic Prostatectomy
14%
Disease Free Survival
14%
Adrenalectomy
14%
Kidney Tumour
14%
Clear Cell Renal Cell Carcinoma
14%
Cancer Therapy
14%
Specific Tumor
14%
Port Site Metastasis
14%
Immunotherapy
14%
Kidney Carcinoma
14%
Surgical Approach
14%
Direct Oral Anticoagulant
14%
Vitamin K Antagonist
14%
Kidney Transplantation
14%
Quality of Life
14%
Recurrence Free Survival
14%
Pelvis Lymphadenectomy
14%
Risk Stratification
14%
B Scan
14%
Disease
12%
Ligation
9%
Marsupialization
8%
Surgery
8%
Retroperitoneal Lymph Node Dissection
8%
Transurethral Resection
8%
Operation Duration
8%
Surgical Technique
8%
Retrospective Study
7%
Pelvis
7%
Lymph Node
7%
Open Surgery
7%
Kidney Function
7%
C Reactive Protein
7%
Interleukin 6
7%
Serum Amyloid A
7%
Cancer Control
7%
Hope
7%
Prostate Disease
7%
Overall Survival
7%
Lymph Duct
6%
Logistic Regression Analysis
6%
Clinical Stage
6%
Flank
5%
Muscle Invasive Bladder Cancer
5%
Patient Referral
5%
Keyphrases
Muscle Invasion
14%
Randomized Evaluation
14%
Metastasizing
14%
Progression Markers
14%
Nodal Staging Score
14%
External Validation
14%
T3N0
14%
Perioperative Risk Stratification
14%
Local Frequency
14%
Hemopatch
14%
Multiplicative Interaction
14%
Laparoscopic Adrenalectomy
14%
Extraperitoneal
14%
Open Radical Prostatectomy
14%
Systemic Response
14%
New Primary
14%
Laparoscopic versus Open
14%
Lymph Node Positive
14%
BCG Infection
14%
Optimal Therapy
14%
Lymphocele
14%
Open Nephrectomy
14%
Gender-dependent
14%
Fluoroethylcholine
14%
High-grade Prostate Cancer
14%
Laparoscopic Partial Nephrectomy
14%
Clinical Application
14%
Artificial Neural Network
14%
Acoustical Parameters
14%
Urothelial Bladder Cancer
14%
Renal Cell Carcinoma
14%
Cystectomy
14%
Locally Advanced Cancer
14%
Locally Advanced
14%
Pathological T Stage
14%
Multicentre Evaluation
14%
Biochemical Outcome
14%
Surgery in Urology
14%
Trocar Placement
14%
B System
14%
Transurethral
14%
Holmium Laser Enucleation
14%
Perioperative Safety
14%
Transrectal Ultrasound
14%
Minimal Invasiveness
14%
Transrectal Sonography
14%
Prospective Nonrandomized Study
14%
Pelvic Cancer
14%
Pelvic Lymphadenectomy
14%
Quinolones
12%
30-day Complications
10%
Resection Speed
10%
Clinical Tumor Stage
9%
Therapy Options
7%
Targeted Therapy
7%
Practical Usefulness
7%
Stage Migration
7%
Muscle-invasive
7%
Liver Retractor
7%
Adrenal Cyst
7%
Mirror Image
7%
Bilateral Adrenal Hyperplasia
7%
Adrenal Myelolipoma
7%
Adrenal Mass
7%
Benign Renal Disease
7%
Kidney Tumor
7%
Parameter Independent
7%
Ultrasound Attenuation
7%
Angiogenesis Inhibitors
7%
Patient Register
7%
Clinical T Stage
7%
Benchmarking Tools
7%
Data Submission
7%
User-friendly Interface
7%
Number of Parameters
7%
MTOR Inhibitor
7%
Acoustic Parameters
7%
B-scan Image
7%
System Effects
7%
Phantom Material
7%
B-mode Ultrasound
7%
Ultrasound Spectroscopy
7%
Clinical Investigator
7%
Backscattering Coefficient
7%
Echo Signal
7%
Specific Parameters
7%
System Parameters
7%
PSA Recurrence
7%
Cancer Control
7%
Microbubbles
7%
Modern Techniques
7%
Prostate Disease
7%
Development Techniques
7%
Color Doppler Ultrasound
7%
Malignant Neoplasms
7%
Ultrasound Equipment
7%
Prostate Cancer Screening
7%
Less Invasiveness
7%
Open Prostatectomy
7%
Laser Enucleation
6%
Pharmacology, Toxicology and Pharmaceutical Science
Transitional Cell Carcinoma
67%
Cancer Staging
61%
Cancer Specific Survival
50%
Prostate Cancer
28%
Gleason Score
25%
Neoplasm
20%
Bladder Cancer
16%
Chemotherapy
14%
Holmium
14%
Serum Amyloid A
14%
Fluorine 18
14%
Direct Oral Anticoagulant
14%
Antivitamin K
14%
Protein Tyrosine Kinase Inhibitor
14%
Mycobacterium Bovis BCG
14%
Cause of Death
14%
Lymph Node Metastasis
14%
Disease Free Survival
14%
Kidney Metastasis
14%
Sunitinib
14%
Recurrence Free Survival
14%
Sorafenib
14%
Lymph Vessel Metastasis
11%
Disease
8%
Survival Rate
8%
Surgical Injury
7%
Tissue Injury
7%
Cancer Recurrence
5%
Muscle Invasive Bladder Cancer
5%